The two enzyme groups remove methyl groups through different chemical routes. LSD1-family enzymes use flavin adenine dinucleotide during oxidative demethylation, whereas JmjC-domain enzymes require iron and 2-oxoglutarate to hydroxylate the methyl group before it is removed. These distinct cofactor requirements provide a mechanistic basis for distinguishing enzyme activities in studies of chromatin regulation.
Activity depends on the enzyme’s selectivity for particular methylated lysine residues and on the catalytic mechanism available to process them. Consequently, different demethylases can influence different chromatin states rather than producing a uniform change across all histones. This site-specific behavior helps connect individual enzymes with particular patterns of gene regulation.
Selective activity allows researchers to relate changes at defined histone sites to broader chromatin and gene-expression outcomes. Instead of treating histone methylation as a single, uniform signal, investigators can examine how particular demethylases reshape specific chromatin states. This precision is especially relevant for understanding differentiation, development, DNA repair, and disease-associated regulation.
By changing methylation patterns on histones, these enzymes can alter chromatin states, which affects how DNA is packaged and how readily genes are expressed. Their effects therefore extend beyond the modified protein itself: changes in histone marks can contribute to cellular programs such as differentiation and development, as well as responses involving DNA repair.
Research commonly connects these enzymes with cell differentiation, development, DNA repair, and regulation of genes associated with disease. Studying their activity in these settings helps explain how chromatin states change as cells acquire specialized functions or respond to genomic stress. It also provides biological context for investigating abnormal gene regulation in disorders.
Their selective effects on methylated lysine residues and gene-regulatory chromatin states make histone demethylases attractive subjects for therapeutic research. If disease-associated gene regulation depends on particular demethylase activities, those enzymes may offer points for intervention. The overview specifically identifies cancer and other disorders as contexts in which this possibility is being explored.